Medicine
Lacosamide 10 mg/mL oral solution
Lacosamide 10 mg/mL oral solution is a generic prescription medicine for oral use, made by 20 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze lacosamide oral solution. Store at 20° to 25°C (68° to 77°F)…
Key facts
- Active ingredient (INN)
- Lacosamide
- Brand
- Sold under the generic name
- Strength
- 10 mg/mL
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 200 mL, 465 mL, 1 bottle and 43 more
- Manufacturers
- Novadoz PharmaceuticalsIndiaAscend LaboratoriesIndiaAurobindo PharmaIndiaCamber PharmaceuticalsIndiaGlenmark PharmaceuticalsIndiaPAI PharmaKesin PharmaChartwell RXChartwell Governmental & Specialty RXKanchan Healthcare20 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Do not freeze lacosamide oral solution. Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CV
- ATC code
- N03AX18 Lacosamide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 May 2022
- Identifiers
- RxCUI 993856DailyMed set ID 75de00d8-d2e7-4025-be4e-f49299068e7e, 458e80da-8fc1-4715-9b4b-bc4f388f933f, ba4e2e28-7dc3-47b3-9c2c-34e0b1f39fb8 +18NDC 0121-2024, 68462-940, 71921-411 +23Application ANDA216151, ANDA215379, ANDA220386 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 20 labelers. The register lists 46 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 200 mL in 1 bottle | 67877-732-95 | Ascend LaboratoriesIndia | 20 May 2022 |
| 465 mL in 1 bottle | 67877-732-97 | Ascend LaboratoriesIndia | 20 May 2022 |
| 200 mL in 1 bottle, plastic | 59651-016-02 | Aurobindo PharmaIndia | 24 January 2024 |
| 465 mL in 1 bottle, plastic | 59651-016-46 | Aurobindo PharmaIndia | 24 January 2024 |
| 1 bottle in 1 carton / 200 mL in 1 bottle | 31722-627-26 | Camber PharmaceuticalsIndia | 31 May 2022 |
| 1 bottle in 1 carton / 465 mL in 1 bottle | 31722-627-46 | Camber PharmaceuticalsIndia | 31 May 2022 |
| 200 mL in 1 bottle, plastic | 68462-940-86 | Glenmark PharmaceuticalsIndia | 30 September 2024 |
| 1 tray in 1 box / 10 cup, unit-dose in 1 tray / 5 mL in 1 cup, unit-dose | 72205-034-50 | Novadoz PharmaceuticalsIndia | 12 December 2024 |
| 200 mL in 1 bottle, plastic | 72205-034-74 | Novadoz PharmaceuticalsIndia | 29 December 2023 |
| 465 mL in 1 bottle, plastic | 72205-034-75 | Novadoz PharmaceuticalsIndia | 29 December 2023 |
| 1 tray in 1 box / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 72205-034-91 | Novadoz PharmaceuticalsIndia | 12 December 2024 |
| 1 tray in 1 box / 10 cup, unit-dose in 1 tray / 15 mL in 1 cup, unit-dose | 72205-034-93 | Novadoz PharmaceuticalsIndia | 12 December 2024 |
| 1 tray in 1 box / 10 cup, unit-dose in 1 tray / 20 mL in 1 cup, unit-dose | 72205-034-94 | Novadoz PharmaceuticalsIndia | 12 December 2024 |
| 3 tray in 1 case / 10 cup, unit-dose in 1 tray / 5 mL in 1 cup, unit-dose | 0121-1012-94 | PAI Pharma | 2 November 2026 |
| 1 tray in 1 case / 10 cup, unit-dose in 1 tray / 5 mL in 1 cup, unit-dose | 0121-1012-95 | PAI Pharma | 28 April 2023 |
| 3 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 0121-2024-94 | PAI Pharma | 2 November 2026 |
| 1 tray in 1 tray / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 0121-2024-95 | PAI Pharma | 28 April 2023 |
| 1 tray in 1 case / 10 cup, unit-dose in 1 tray / 15 mL in 1 cup, unit-dose | 0121-3036-95 | PAI Pharma | 30 June 2023 |
| 1 tray in 1 case / 10 cup, unit-dose in 1 tray / 20 mL in 1 cup, unit-dose | 0121-4048-95 | PAI Pharma | 26 August 2022 |
| 200 mL in 1 bottle, plastic | 82983-427-31 | Ajenat Pharmaceuticals | 14 July 2025 |
| 200 mL in 1 bottle, plastic | 70954-488-10 | ANI Pharmaceuticals | 26 August 2022 |
| 2 tray in 1 box / 10 cup in 1 tray / 10 mL in 1 cup | 68999-885-23 | Chartwell Governmental & Specialty RX | 14 January 2026 |
| 2 tray in 1 box / 10 cup in 1 tray / 5 mL in 1 cup | 68999-885-24 | Chartwell Governmental & Specialty RX | 14 January 2026 |
| 200 mL in 1 bottle | 62135-885-22 | Chartwell RX | 27 November 2024 |
| 2 tray in 1 box / 10 cup in 1 tray / 10 mL in 1 cup | 62135-885-23 | Chartwell RX | 10 February 2025 |
| 2 tray in 1 box / 10 cup in 1 tray / 5 mL in 1 cup | 62135-885-24 | Chartwell RX | 10 February 2025 |
| 1 bottle in 1 carton / 200 mL in 1 bottle | 71921-411-71 | Florida Pharmaceutical Products | 30 January 2026 |
| 200 mL in 1 bottle, plastic | 85742-014-13 | Kanchan Healthcare | 25 July 2023 |
| 465 mL in 1 bottle, plastic | 85742-014-14 | Kanchan Healthcare | 25 July 2023 |
| 200 mL in 1 bottle, plastic | 69315-318-20 | Leading Pharma | 25 July 2023 |
| 465 mL in 1 bottle, plastic | 69315-318-46 | Leading Pharma | 25 July 2023 |
| 10 cup, unit-dose in 1 carton / 5 mL in 1 cup, unit-dose | 81033-427-14 | Kesin Pharmaceutical | 5 August 2025 |
| 10 cup, unit-dose in 1 carton / 10 mL in 1 cup, unit-dose | 81033-427-16 | Kesin Pharmaceutical | 5 August 2025 |
| 10 cup, unit-dose in 1 carton / 15 mL in 1 cup, unit-dose | 81033-427-17 | Kesin Pharmaceutical | 5 August 2025 |
| 10 cup, unit-dose in 1 carton / 20 mL in 1 cup, unit-dose | 81033-427-18 | Kesin Pharmaceutical | 5 August 2025 |
| 200 mL in 1 bottle, plastic | 81033-428-02 | Kesin Pharma | 14 July 2025 |
| 1 tray in 1 case / 10 cup, unit-dose in 1 tray / 5 mL in 1 cup, unit-dose | 0904-7463-68 | Major Pharmaceuticals | 28 April 2023 |
| 1 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 0904-7464-64 | Major Pharmaceuticals | 26 June 2024 |
| 3 tray in 1 case / 10 cup, unit-dose in 1 tray / 5 mL in 1 cup, unit-dose | 68094-076-62 | Precision Dose | 22 September 2025 |
| 3 tray in 1 case / 10 cup, unit-dose in 1 tray / 10 mL in 1 cup, unit-dose | 68094-176-62 | Precision Dose | 22 September 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Lacosamide 10 mg/mL oral solution.
Other strengths and forms of Lacosamide
Clinical summary
Lacosamide is a prescription medicine indicated for treatment of partial-onset seizures in patients 1 month of age and older, among other approved uses. It is available as tablets, oral solution and injection for intravenous use. MedsAcross supplies Lacosamide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LacosamideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Vimpat prescribing information (UCB) · U.S. National Library of Medicine, DailyMed
- Lacosamide UCB: European public assessment report (EPAR) · European Medicines Agency
- Vimpat: European public assessment report (EPAR) · European Medicines Agency
Need Lacosamide 10 mg/mL oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.